モノアミン酸化酵素 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "モノアミン酸化酵素" in Japanese language version.

refsWebsite

Global rank Japanese rank

39nih.gov

4^th place

24^th place

25doi.org

2^nd place

6^th place

4worldcat.org

5^th place

19^th place

1zenodo.org

621^st place

4,635^th place

doi.org

“Monoamine oxidases: certainties and uncertainties”. Current Medicinal Chemistry 11 (15): 1965–82. (August 2004). doi:10.2174/0929867043364810. PMID 15279561.
“Structure and mechanism of monoamine oxidase”. Current Medicinal Chemistry 11 (15): 1983–93. (August 2004). doi:10.2174/0929867043364784. PMID 15279562.
“Tyramine oxidase: A new enzyme system in liver”. The Biochemical Journal 22 (4): 968–79. (1928). doi:10.1042/bj0220968. PMC 1252213. PMID 16744124.
“Mary Bernheim and the discovery of monoamine oxidase”. Brain Research Bulletin 50 (5–6): 373. (1999). doi:10.1016/S0361-9230(99)00110-0. PMID 10643441.
“Regulation of MAO-A and MAO-B gene expression”. Current Medicinal Chemistry 11 (15): 1995–2005. (August 2004). doi:10.2174/0929867043364757. PMID 15279563.
“Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies”. Journal of Cerebral Blood Flow and Metabolism 33 (6): 863–71. (June 2013). doi:10.1038/jcbfm.2013.19. PMC 3677103. PMID 23403377.
“Structures and Mechanism of the Monoamine Oxidase Family”. Biomolecular Concepts 2 (5): 365–377. (October 2011). doi:10.1515/BMC.2011.030. PMC 3197729. PMID 22022344.
“Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors”. Chemical Research in Toxicology 14 (9): 1139–62. (September 2001). doi:10.1021/tx010073b. PMID 11559028.
“Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients”. The American Journal of Psychiatry 133 (3): 323–6. (March 1976). doi:10.1176/ajp.133.3.323. PMID 943955.
“Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients”. The American Journal of Psychiatry 133 (4): 438–40. (April 1976). doi:10.1176/ajp.133.4.438. PMID 1267046.
“Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression”. Archives of General Psychiatry 63 (11): 1209–16. (November 2006). doi:10.1001/archpsyc.63.11.1209. PMID 17088501.
“Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children”. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 134B (1): 110–4. (April 2005). doi:10.1002/ajmg.b.30158. PMID 15717295.
“Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection”. Neurotoxicology 25 (1–2): 79–89. (January 2004). doi:10.1016/S0161-813X(03)00115-3. PMID 14697883.
“Monoamine oxidases A and B gene polymorphisms in migraine patients”. Journal of the Neurological Sciences 228 (2): 149–53. (February 2005). doi:10.1016/j.jns.2004.11.045. PMID 15694196.
“Clinical applications of MAO-inhibitors”. Current Medicinal Chemistry 11 (15): 2033–43. (August 2004). doi:10.2174/0929867043364775. PMID 15279566.
“The role of monoamine oxidase inhibitors in current psychiatric practice”. Journal of Psychiatric Practice 10 (4): 239–48. (July 2004). doi:10.1097/00131746-200407000-00005. PMC 2075358. PMID 15552546.
“Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition”. Journal of Addictive Diseases 17 (1): 23–34. (1998). doi:10.1300/J069v17n01_03. PMID 9549600.
“Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain”. Psychopharmacology 72 (1): 27–33. (1980). doi:10.1007/bf00433804. PMID 6781004.
“Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B”. Neurotoxicology 25 (1–2): 21–30. (January 2004). doi:10.1016/s0161-813x(03)00112-8. PMID 14697877.
Brunner, H. G.; Nelen, M.; Breakefield, X. O.; Ropers, H. H.; van Oost, B. A. (1993-10-22). “Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A”. Science (New York, N.Y.) 262 (5133): 578–580. doi:10.1126/science.8211186. ISSN 0036-8075. PMID 8211186.
“Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participants”. Psychiatric Genetics 16 (2): 55–8. (April 2006). doi:10.1097/01.ypg.0000199447.62044.ef. PMID 16538181.
“Role of genotype in the cycle of violence in maltreated children”. Science 297 (5582): 851–4. (August 2002). doi:10.1126/science.1072290. PMID 12161658.
“A functional polymorphism in the monoamine oxidase A gene promoter”. Human Genetics 103 (3): 273–9. (September 1998). doi:10.1007/s004390050816. PMID 9799080. https://zenodo.org/record/1232725.
“Monoamine oxidase expression during development and aging”. Neurotoxicology 25 (1–2): 155–65. (January 2004). doi:10.1016/S0161-813X(03)00095-0. PMID 14697890.
“Monoamine oxidase activity in the rat pineal gland: Comparison with brain areas and alteration during aging”. Advances in Gerontology 6 (2): 111–116. (2016-07-14). doi:10.1134/S2079057016020120. ISSN 2079-0570.

nih.gov

pubmed.ncbi.nlm.nih.gov

“Monoamine oxidases: certainties and uncertainties”. Current Medicinal Chemistry 11 (15): 1965–82. (August 2004). doi:10.2174/0929867043364810. PMID 15279561.
“Structure and mechanism of monoamine oxidase”. Current Medicinal Chemistry 11 (15): 1983–93. (August 2004). doi:10.2174/0929867043364784. PMID 15279562.
“Tyramine oxidase: A new enzyme system in liver”. The Biochemical Journal 22 (4): 968–79. (1928). doi:10.1042/bj0220968. PMC 1252213. PMID 16744124.
“Mary Bernheim and the discovery of monoamine oxidase”. Brain Research Bulletin 50 (5–6): 373. (1999). doi:10.1016/S0361-9230(99)00110-0. PMID 10643441.
“Regulation of MAO-A and MAO-B gene expression”. Current Medicinal Chemistry 11 (15): 1995–2005. (August 2004). doi:10.2174/0929867043364757. PMID 15279563.
“Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies”. Journal of Cerebral Blood Flow and Metabolism 33 (6): 863–71. (June 2013). doi:10.1038/jcbfm.2013.19. PMC 3677103. PMID 23403377.
“Structures and Mechanism of the Monoamine Oxidase Family”. Biomolecular Concepts 2 (5): 365–377. (October 2011). doi:10.1515/BMC.2011.030. PMC 3197729. PMID 22022344.
“Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors”. Chemical Research in Toxicology 14 (9): 1139–62. (September 2001). doi:10.1021/tx010073b. PMID 11559028.
“Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients”. The American Journal of Psychiatry 133 (3): 323–6. (March 1976). doi:10.1176/ajp.133.3.323. PMID 943955.
“Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients”. The American Journal of Psychiatry 133 (4): 438–40. (April 1976). doi:10.1176/ajp.133.4.438. PMID 1267046.
“Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression”. Archives of General Psychiatry 63 (11): 1209–16. (November 2006). doi:10.1001/archpsyc.63.11.1209. PMID 17088501.
“Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children”. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 134B (1): 110–4. (April 2005). doi:10.1002/ajmg.b.30158. PMID 15717295.
“Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection”. Neurotoxicology 25 (1–2): 79–89. (January 2004). doi:10.1016/S0161-813X(03)00115-3. PMID 14697883.
“Monoamine oxidase activities in patients with migraine or with cluster headache during the acute phases and after treatment with L-5-hydroxytryptophan”. Rivista di Patologia Nervosa e Mentale 100 (5): 269–74. (1 October 2016). PMID 318025.
“Monoamine oxidases A and B gene polymorphisms in migraine patients”. Journal of the Neurological Sciences 228 (2): 149–53. (February 2005). doi:10.1016/j.jns.2004.11.045. PMID 15694196.
“Clinical applications of MAO-inhibitors”. Current Medicinal Chemistry 11 (15): 2033–43. (August 2004). doi:10.2174/0929867043364775. PMID 15279566.
“The role of monoamine oxidase inhibitors in current psychiatric practice”. Journal of Psychiatric Practice 10 (4): 239–48. (July 2004). doi:10.1097/00131746-200407000-00005. PMC 2075358. PMID 15552546.
“Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition”. Journal of Addictive Diseases 17 (1): 23–34. (1998). doi:10.1300/J069v17n01_03. PMID 9549600.
“Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain”. Psychopharmacology 72 (1): 27–33. (1980). doi:10.1007/bf00433804. PMID 6781004.
“Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B”. Neurotoxicology 25 (1–2): 21–30. (January 2004). doi:10.1016/s0161-813x(03)00112-8. PMID 14697877.
Brunner, H. G.; Nelen, M.; Breakefield, X. O.; Ropers, H. H.; van Oost, B. A. (1993-10-22). “Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A”. Science (New York, N.Y.) 262 (5133): 578–580. doi:10.1126/science.8211186. ISSN 0036-8075. PMID 8211186.
“Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participants”. Psychiatric Genetics 16 (2): 55–8. (April 2006). doi:10.1097/01.ypg.0000199447.62044.ef. PMID 16538181.
“Role of genotype in the cycle of violence in maltreated children”. Science 297 (5582): 851–4. (August 2002). doi:10.1126/science.1072290. PMID 12161658.
Merriman, Tony; Cameron, Vicky (2007-03-02). “Risk-taking: behind the warrior gene story”. The New Zealand Medical Journal 120 (1250): U2440. ISSN 1175-8716. PMID 17339896.
“A functional polymorphism in the monoamine oxidase A gene promoter”. Human Genetics 103 (3): 273–9. (September 1998). doi:10.1007/s004390050816. PMID 9799080. https://zenodo.org/record/1232725.
Lea, Rod; Chambers, Geoffrey (2007-03-02). “Monoamine oxidase, addiction, and the "warrior" gene hypothesis”. The New Zealand Medical Journal 120 (1250): U2441. ISSN 1175-8716. PMID 17339897.
“Monoamine oxidase expression during development and aging”. Neurotoxicology 25 (1–2): 155–65. (January 2004). doi:10.1016/S0161-813X(03)00095-0. PMID 14697890.

ncbi.nlm.nih.gov

“Tyramine oxidase: A new enzyme system in liver”. The Biochemical Journal 22 (4): 968–79. (1928). doi:10.1042/bj0220968. PMC 1252213. PMID 16744124.
Yeung AWK, Georgieva MG, Atanasov AG, Tzvetkov NT. Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis. Front Mol Neurosci. 2019 May 29;12:143. doi: 10.3389/fnmol.2019.00143.
“Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies”. Journal of Cerebral Blood Flow and Metabolism 33 (6): 863–71. (June 2013). doi:10.1038/jcbfm.2013.19. PMC 3677103. PMID 23403377.
“Structures and Mechanism of the Monoamine Oxidase Family”. Biomolecular Concepts 2 (5): 365–377. (October 2011). doi:10.1515/BMC.2011.030. PMC 3197729. PMID 22022344.
“The role of monoamine oxidase inhibitors in current psychiatric practice”. Journal of Psychiatric Practice 10 (4): 239–48. (July 2004). doi:10.1097/00131746-200407000-00005. PMC 2075358. PMID 15552546.
Brunner, H. G.; Nelen, M.; Breakefield, X. O.; Ropers, H. H.; van Oost, B. A. (1993-10-22). “Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A”. Science (New York, N.Y.) 262 (5133): 578–580. doi:10.1126/science.8211186. ISSN 0036-8075. PMID 8211186.
Merriman, Tony; Cameron, Vicky (2007-03-02). “Risk-taking: behind the warrior gene story”. The New Zealand Medical Journal 120 (1250): U2440. ISSN 1175-8716. PMID 17339896.
Lea, Rod; Chambers, Geoffrey (2007-03-02). “Monoamine oxidase, addiction, and the "warrior" gene hypothesis”. The New Zealand Medical Journal 120 (1250): U2441. ISSN 1175-8716. PMID 17339897.

pmc.ncbi.nlm.nih.gov

worldcat.org

search.worldcat.org

Brunner, H. G.; Nelen, M.; Breakefield, X. O.; Ropers, H. H.; van Oost, B. A. (1993-10-22). “Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A”. Science (New York, N.Y.) 262 (5133): 578–580. doi:10.1126/science.8211186. ISSN 0036-8075. PMID 8211186.
Merriman, Tony; Cameron, Vicky (2007-03-02). “Risk-taking: behind the warrior gene story”. The New Zealand Medical Journal 120 (1250): U2440. ISSN 1175-8716. PMID 17339896.
Lea, Rod; Chambers, Geoffrey (2007-03-02). “Monoamine oxidase, addiction, and the "warrior" gene hypothesis”. The New Zealand Medical Journal 120 (1250): U2441. ISSN 1175-8716. PMID 17339897.
“Monoamine oxidase activity in the rat pineal gland: Comparison with brain areas and alteration during aging”. Advances in Gerontology 6 (2): 111–116. (2016-07-14). doi:10.1134/S2079057016020120. ISSN 2079-0570.

zenodo.org

“A functional polymorphism in the monoamine oxidase A gene promoter”. Human Genetics 103 (3): 273–9. (September 1998). doi:10.1007/s004390050816. PMID 9799080. https://zenodo.org/record/1232725.